Göran Gannedahl
Directeur/Bestuurslid bij ECTIN RESEARCH AB
Profiel
Göran Gannedahl is currently the Director at Ectin Research AB since 2022.
Previously, he worked as the VP-Medical, Regulatory Affairs & Research at Pronova BioPharma ASA from 2008 to 2012.
He holds a doctorate degree from Karolinska Institutet and the University of Uppsala.
Actieve functies van Göran Gannedahl
| Bedrijven | Functie | Begin |
|---|---|---|
| ECTIN RESEARCH AB | Directeur/Bestuurslid | 01-05-2022 |
Eerdere bekende functies van Göran Gannedahl
| Bedrijven | Functie | Einde |
|---|---|---|
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Göran Gannedahl
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ECTIN RESEARCH AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |